
Judge demands Pentagon justify testosterone policy amid transgender troops dispute
A federal judge ordered the Pentagon to explain why its new plan to screen cisgender soldiers 30+ for testosterone and offer testosterone replacement therapy differs from its ban on transgender troops, requesting the medical rationale, cost, and implementation details before an August 7 hearing as doctors warn of TRT risks and lawmakers scrutinize the policy amid ongoing transgender-service lawsuits.

